Results
|
|
161.
|
Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug reSistant patients with Tipranavir (RESIST) studies: an analysis of combined data from two randomised open-label trials. [electronic resource] by
- Hicks, Charles B
- Cahn, Pedro
- Cooper, David A
- Walmsley, Sharon L
- Katlama, Christine
- Clotet, Bonaventura
- Lazzarin, Adriano
- Johnson, Margaret A
- Neubacher, Dietmar
- Mayers, Douglas
- Valdez, Hernan
Producer: 20060822
In:
Lancet (London, England) vol. 368
Availability: No items available.
|
|
|
162.
|
|
|
|
163.
|
Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naïve HIV-1-Infected Patients: A Randomized, Multinational, Multicenter Trial. [electronic resource] by
- Cooper, David A
- Cordery, Damien V
- Zajdenverg, Roberto
- Ruxrungtham, Kiat
- Arastéh, Keikawus
- Bergmann, Frank
- Neto, José L de Andrade
- Scherer, Joseph
- Chaves, Ricardo L
- Robinson, Patrick
Producer: 20160712
In:
PloS one vol. 11
Availability: No items available.
|
|
|
164.
|
Specific antibody-dependent cellular cytotoxicity responses associated with slow progression of HIV infection. [electronic resource] by
- Wren, Leia H
- Chung, Amy W
- Isitman, Gamze
- Kelleher, Anthony D
- Parsons, Matthew S
- Amin, Janaki
- Cooper, David A
- Stratov, Ivan
- Navis, Marjon
- Kent, Stephen J
Producer: 20130311
In:
Immunology vol. 138
Availability: No items available.
|
|
|
165.
|
|
|
|
166.
|
Promoter Targeting shRNA Suppresses HIV-1 Infection In vivo Through Transcriptional Gene Silencing. [electronic resource] by
- Suzuki, Kazuo
- Hattori, Shinichiro
- Marks, Katherine
- Ahlenstiel, Chantelle
- Maeda, Yosuke
- Ishida, Takaomi
- Millington, Michelle
- Boyd, Maureen
- Symonds, Geoff
- Cooper, David A
- Okada, Seiji
- Kelleher, Anthony D
Producer: 20131204
In:
Molecular therapy. Nucleic acids vol. 2
Availability: No items available.
|
|
|
167.
|
|
|
|
168.
|
HIV DNA subspecies persist in both activated and resting memory CD4+ T cells during antiretroviral therapy. [electronic resource] by
- Murray, John M
- Zaunders, John J
- McBride, Kristin L
- Xu, Yin
- Bailey, Michelle
- Suzuki, Kazuo
- Cooper, David A
- Emery, Sean
- Kelleher, Anthony D
- Koelsch, Kersten K
Producer: 20140512
In:
Journal of virology vol. 88
Availability: No items available.
|
|
|
169.
|
|
|
|
170.
|
A prospective study of efficacy and safety of once-daily saquinavir/ritonavir plus two nucleoside reverse transcriptase inhibitors in treatment-naive Thai patients. [electronic resource] by
- Ananworanich, Jintanat
- Hill, Andrew
- Siangphoe, Umaporn
- Ruxrungtham, Kiat
- Prasithsirikul, Wisit
- Chetchotisakd, Ploenchan
- Kiertiburanakul, Sasisopin
- Munsakul, Warangkana
- Raksakulkarn, Phitsanu
- Tansuphasawadikul, Somboon
- Nuesch, Reto
- Cooper, David A
- Hirschel, Bernard
Producer: 20051115
In:
Antiviral therapy vol. 10
Availability: No items available.
|
|
|
171.
|
In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA. [electronic resource] by
- Mallon, Patrick W G
- Unemori, Patrick
- Sedwell, Rebecca
- Morey, Adrienne
- Rafferty, Martina
- Williams, Kenneth
- Chisholm, Donald
- Samaras, Katherine
- Emery, Sean
- Kelleher, Anthony
- Cooper, David A
- Carr, Andrew
Producer: 20050628
In:
The Journal of infectious diseases vol. 191
Availability: No items available.
|
|
|
172.
|
Progressive activation of CD127+132- recent thymic emigrants into terminally differentiated CD127-132+ T-cells in HIV-1 infection. [electronic resource] by
- Sasson, Sarah C
- Zaunders, John J
- Seddiki, Nabila
- Bailey, Michelle
- McBride, Kristin
- Koelsch, Kersten K
- Merlin, Kate M
- Smith, Don E
- Cooper, David A
- Kelleher, Anthony D
Producer: 20120731
In:
PloS one vol. 7
Availability: No items available.
|
|
|
173.
|
Disease-modifying therapeutic concepts for HIV in the era of highly active antiretroviral therapy. [electronic resource] by
- Butler, Scott L
- Valdez, Hernan
- Westby, Michael
- Perros, Manos
- June, Carl H
- Jacobson, Jeffrey M
- Levy, Yves
- Cooper, David A
- Douek, Daniel
- Lederman, Michael M
- Tebas, Pablo
Producer: 20111207
In:
Journal of acquired immune deficiency syndromes (1999) vol. 58
Availability: No items available.
|
|
|
174.
|
Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1: 5-year findings. [electronic resource] by
- Cooper, David A
- Heera, Jayvant
- Ive, Prudence
- Botes, Mariette
- Dejesus, Edwin
- Burnside, Robert
- Clumeck, Nathan
- Walmsley, Sharon
- Lazzarin, Adriano
- Mukwaya, Geoffrey
- Saag, Michael
- van Der Ryst, Elna
Producer: 20150220
In:
AIDS (London, England) vol. 28
Availability: No items available.
|
|
|
175.
|
Modeling of Experimental Data Supports HIV Reactivation from Latency after Treatment Interruption on Average Once Every 5-8 Days. [electronic resource] by
- Pinkevych, Mykola
- Kent, Stephen J
- Tolstrup, Martin
- Lewin, Sharon R
- Cooper, David A
- Søgaard, Ole S
- Rasmussen, Thomas A
- Kelleher, Anthony D
- Cromer, Deborah
- Davenport, Miles P
Producer: 20190225
In:
PLoS pathogens vol. 12
Availability: No items available.
|
|
|
176.
|
|
|
|
177.
|
Relationships between drug exposure, changes in metabolic parameters and body fat in HIV-infected patients switched to a nucleoside sparing regimen. [electronic resource] by
- Autar, Reshma S
- Boyd, Mark A
- Wit, Ferdinand W M N
- Ruxrungthams, Kiat
- Sankote, Jongkol
- Lange, Joep
- Cooper, David A
- Phanuphak, Praphan
- Burger, David M
- Reiss, Peter
Producer: 20080312
In:
Antiviral therapy vol. 12
Availability: No items available.
|
|
|
178.
|
Validation of RNA-based molecular clonotype analysis for virus-specific CD8+ T-cells in formaldehyde-fixed specimens isolated from peripheral blood. [electronic resource] by
- van Bockel, David
- Price, David A
- Asher, Tedi E
- Venturi, Vanessa
- Suzuki, Kazuo
- Warton, Kristina
- Davenport, Miles P
- Cooper, David A
- Douek, Daniel C
- Kelleher, Anthony D
Producer: 20071030
In:
Journal of immunological methods vol. 326
Availability: No items available.
|
|
|
179.
|
Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection. [electronic resource] by
- Hamlyn, Elizabeth
- Ewings, Fiona M
- Porter, Kholoud
- Cooper, David A
- Tambussi, Giuseppe
- Schechter, Mauro
- Pedersen, Court
- Okulicz, Jason F
- McClure, Myra
- Babiker, Abdel
- Weber, Jonathan
- Fidler, Sarah
Producer: 20130219
In:
PloS one vol. 7
Availability: No items available.
|
|
|
180.
|
Efficacy and safety of lersivirine (UK-453,061) versus efavirenz in antiretroviral treatment-naive HIV-1-infected patients: week 48 primary analysis results from an ongoing, multicenter, randomized, double-blind, phase IIb trial. [electronic resource] by
- Vernazza, Pietro
- Wang, Cunshan
- Pozniak, Anton
- Weil, Elizabeth
- Pulik, Piotr
- Cooper, David A
- Kaplan, Richard
- Lazzarin, Adriano
- Valdez, Hernan
- Goodrich, James
- Mori, Julie
- Craig, Charles
- Tawadrous, Margaret
Producer: 20130308
In:
Journal of acquired immune deficiency syndromes (1999) vol. 62
Availability: No items available.
|